A phase 3, multicenter, randomized, double-blind, comparative study of the efficacy and safety of tigecycline vs imipenem/cilastatin for the treatment of subjects with nosocomial pneumonia

Trial Profile

A phase 3, multicenter, randomized, double-blind, comparative study of the efficacy and safety of tigecycline vs imipenem/cilastatin for the treatment of subjects with nosocomial pneumonia

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Sep 2007

At a glance

  • Drugs Imipenem/cilastatin; Tigecycline
  • Indications Bacterial infections; Nosocomial pneumonia
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Sep 2007 Status changed from in progress to completed.
    • 29 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top